FHD-609
In Stock•Starting at $163 for 10 mg•Purity ≥ 99%
| CAS No. | 2676211-64-4 |
|---|---|
| MDL No. | N/A |
| MF | C47H56N8O6 |
| MW | 829.00 |
| InChI Key | OBNRBCUHEAAFPS-KDXMTYKHSA-N |
| CAS No. | 2676211-64-4 |
|---|---|
| MDL No. | N/A |
| MF | C47H56N8O6 |
| MW | 829.00 |
| InChI Key | OBNRBCUHEAAFPS-KDXMTYKHSA-N |
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| 10 mg | 99% | $163 | In Stock | |
| 25 mg | 99% | $294 | In Stock | |
| 50 mg | 99% | $469 | In Stock | |
| 100 mg | 99% | $926 | In Stock | |
| 250 mg | 99% | $1572 | In Stock | |
| Custom synthesis and bulk supply options are available upon request. | ||||
FHD-609 is a PROTAC degrader and BRD9 inhibitor that targets ncBAF, suitable for research on cancers with mutations in BAF complex subunits.
| CAS No. | 2676211-64-4 |
|---|---|
| Product Name | FHD-609 |
| Heavy Atom Count | 61 | Rotatable Bond Count | 10 |
| Atom Stereo Count | 1 | Bond Stereo Count | 0 |
| HBA | 12 | HBD | 1 |
| TPSA | 132.790 Ų | Charge | 0 |
| Exact Mass | 828.43228 | Complexity | 2432.06 |
| pKa | 5.875 | XLogP | 4.403 |